Concord Medical Services Holdings Limited (CCM) Receives Consensus Recommendation of “Sell” from Analysts

Concord Medical Services Holdings Limited (NYSE:CCM) has been given a consensus broker rating score of 3.70 (Sell) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a sell rating.

Brokers have set a 1 year consensus price objective of $3.00 for the company, according to Zacks. Zacks has also assigned Concord Medical Services Holdings Limited an industry rank of 233 out of 265 based on the ratings given to related companies.

Separately, Zacks Investment Research cut Concord Medical Services Holdings Limited from a “buy” rating to a “hold” rating in a research report on Monday, September 4th.

Shares of Concord Medical Services Holdings Limited (CCM) traded up $0.02 during midday trading on Monday, reaching $3.93. The company’s stock had a trading volume of 8,300 shares, compared to its average volume of 21,957. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.60 and a quick ratio of 1.59. Concord Medical Services Holdings Limited has a fifty-two week low of $3.22 and a fifty-two week high of $4.96.

ILLEGAL ACTIVITY WARNING: This story was originally reported by TrueBlueTribune and is owned by of TrueBlueTribune. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://www.truebluetribune.com/2017/11/20/concord-medical-services-holdings-limited-ccm-receives-consensus-recommendation-of-sell-from-analysts.html.

An institutional investor recently raised its position in Concord Medical Services Holdings Limited stock. Renaissance Technologies LLC grew its holdings in Concord Medical Services Holdings Limited (NYSE:CCM) by 48.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 199,100 shares of the company’s stock after purchasing an additional 64,600 shares during the period. Renaissance Technologies LLC owned approximately 1.37% of Concord Medical Services Holdings Limited worth $940,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 12.49% of the company’s stock.

Concord Medical Services Holdings Limited Company Profile

Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company’s segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China.

Get a free copy of the Zacks research report on Concord Medical Services Holdings Limited (CCM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Concord Medical Services Holdings Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services Holdings Limited and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply